BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32462312)

  • 1. High prevalence of pro-thrombotic conditions in adult patients with moyamoya disease and moyamoya syndrome: a single center study.
    Larson A; Rinaldo L; Lanzino G; Klaas JP
    Acta Neurochir (Wien); 2020 Aug; 162(8):1853-1859. PubMed ID: 32462312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.
    Scala M; Fiaschi P; Capra V; Garrè ML; Tortora D; Ravegnani M; Pavanello M
    Childs Nerv Syst; 2018 Jul; 34(7):1311-1323. PubMed ID: 29797062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between moyamoya disease and moyamoya syndrome in Israel.
    Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More Precise Imaging Analysis and Diagnosis of Moyamoya Disease and Moyamoya Syndrome Using High-Resolution Magnetic Resonance Imaging.
    Yu LB; He H; Zhao JZ; Wang R; Zhang Q; Shi ZY; Shao JS; Zhang D
    World Neurosurg; 2016 Dec; 96():252-260. PubMed ID: 27576769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres.
    Feghali J; Xu R; Yang W; Liew JA; Blakeley J; Ahn ES; Tamargo RJ; Huang J
    J Neurosurg; 2019 Oct; 133(5):1441-1449. PubMed ID: 31585423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failures in Revascularization for Pediatric Moyamoya Disease and Syndrome: A Scoping Review.
    Shlobin NA; Frankel HG; Lam S
    World Neurosurg; 2021 May; 149():204-214.e1. PubMed ID: 33618047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.
    Po' C; Nosadini M; Zedde M; Pascarella R; Mirone G; Cicala D; Rosati A; Cosi A; Toldo I; Colombatti R; Martelli P; Iodice A; Accorsi P; Giordano L; Savasta S; Foiadelli T; Sanfilippo G; Lafe E; Thyrion FZ; Polonara G; Campa S; Raviglione F; Scelsa B; Bova SM; Greco F; Cordelli DM; Cirillo L; Toni F; Baro V; Causin F; Frigo AC; Suppiej A; Sainati L; Azzolina D; Agostini M; Cesaroni E; De Carlo L; Di Rosa G; Esposito G; Grazian L; Morini G; Nicita F; Operto FF; Pruna D; Ragazzi P; Rollo M; Spalice A; Striano P; Skabar A; Lanterna LA; Carai A; Marras CE; Manara R; Sartori S
    Front Pediatr; 2022; 10():892445. PubMed ID: 35601411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.
    Larson AS; Savastano L; Klaas J; Lanzino G
    Neurosurg Rev; 2021 Jun; 44(3):1429-1436. PubMed ID: 32507930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study.
    Wang Y; Li M; Wang J
    Front Neurol; 2022; 13():1041886. PubMed ID: 36601296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.
    Yu L; Ma L; Huang Z; Shi Z; Wang R; Zhao Y; Zhang D
    World Neurosurg; 2019 Aug; 128():e582-e596. PubMed ID: 31059856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.